138 related articles for article (PubMed ID: 26497687)
1. Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma.
Slezak-Prochazka I; Kluiver J; de Jong D; Smigielska-Czepiel K; Kortman G; Winkle M; Rutgers B; Koerts J; Visser L; Diepstra A; Kroesen BJ; van den Berg A
Oncotarget; 2016 Jan; 7(3):2391-400. PubMed ID: 26497687
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
[TBL] [Abstract][Full Text] [Related]
3. miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis.
Yuan Y; Kluiver J; Koerts J; de Jong D; Rutgers B; Abdul Razak FR; Terpstra M; Plaat BE; Nolte IM; Diepstra A; Visser L; Kok K; van den Berg A
Am J Pathol; 2017 Jun; 187(6):1343-1355. PubMed ID: 28432871
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.
Schneider C; Setty M; Holmes AB; Maute RL; Leslie CS; Mussolin L; Rosolen A; Dalla-Favera R; Basso K
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8185-90. PubMed ID: 24843176
[TBL] [Abstract][Full Text] [Related]
5. NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomas.
Reed SM; Hagen J; Muniz VP; Rosean TR; Borcherding N; Sciegienka S; Goeken JA; Naumann PW; Zhang W; Tompkins VS; Janz S; Meyerholz DK; Quelle DE
PLoS One; 2014; 9(11):e112126. PubMed ID: 25393878
[TBL] [Abstract][Full Text] [Related]
6. The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
Ziel-Swier LJYM; Liu Y; Seitz A; de Jong D; Koerts J; Rutgers B; Veenstra R; Razak FRA; Dzikiewicz-Krawczyk A; van den Berg A; Kluiver J
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205272
[TBL] [Abstract][Full Text] [Related]
7. Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells.
Dzikiewicz-Krawczyk A; Diepstra A; Rutgers B; Kortman G; de Jong D; Koerts J; Bulthuis M; van der Sluis T; Seitz A; Visser L; Kok K; Kluiver J; van den Berg A
Am J Pathol; 2018 May; 188(5):1289-1299. PubMed ID: 29458013
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.
Gibcus JH; Tan LP; Harms G; Schakel RN; de Jong D; Blokzijl T; Möller P; Poppema S; Kroesen BJ; van den Berg A
Neoplasia; 2009 Feb; 11(2):167-76. PubMed ID: 19177201
[TBL] [Abstract][Full Text] [Related]
9. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
[TBL] [Abstract][Full Text] [Related]
10. MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma.
Gibcus JH; Kroesen BJ; Koster R; Halsema N; de Jong D; de Jong S; Poppema S; Kluiver J; Diepstra A; van den Berg A
J Pathol; 2011 Dec; 225(4):609-17. PubMed ID: 21953646
[TBL] [Abstract][Full Text] [Related]
11. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma.
van den Berg A; Kroesen BJ; Kooistra K; de Jong D; Briggs J; Blokzijl T; Jacobs S; Kluiver J; Diepstra A; Maggio E; Poppema S
Genes Chromosomes Cancer; 2003 May; 37(1):20-8. PubMed ID: 12661002
[TBL] [Abstract][Full Text] [Related]
12. MiR-378a-3p Is Critical for Burkitt Lymphoma Cell Growth.
Niu F; Dzikiewicz-Krawczyk A; Koerts J; de Jong D; Wijenberg L; Fernandez Hernandez M; Slezak-Prochazka I; Winkle M; Kooistra W; van der Sluis T; Rutgers B; Terpstra MM; Kok K; Kluiver J; van den Berg A
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33261009
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.
Jeong D; Kim J; Nam J; Sun H; Lee YH; Lee TJ; Aguiar RC; Kim SW
Leukemia; 2015 Sep; 29(9):1868-74. PubMed ID: 25915824
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.
Ferreira AC; Robaina MC; Rezende LM; Severino P; Klumb CE
Ann Hematol; 2014 Jun; 93(6):983-93. PubMed ID: 24577510
[TBL] [Abstract][Full Text] [Related]
15. Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.
Wang M; Yang W; Li M; Li Y
Exp Mol Pathol; 2014 Apr; 96(2):261-6. PubMed ID: 24613688
[TBL] [Abstract][Full Text] [Related]
16. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
[TBL] [Abstract][Full Text] [Related]
17. Argonaute 2 immunoprecipitation revealed large tumor suppressor kinase 1 as a novel proapoptotic target of miR-21 in T cells.
Teteloshvili N; Smigielska-Czepiel K; Yuan Y; Seitz A; de Jong D; Rutgers B; Jellema P; van der Lei RJ; Slezak-Prochazka I; Brouwer E; Boots AM; Kroesen BJ; van den Berg A; Kluiver J
FEBS J; 2017 Feb; 284(4):555-567. PubMed ID: 28075055
[TBL] [Abstract][Full Text] [Related]
18. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
Kluiver J; Haralambieva E; de Jong D; Blokzijl T; Jacobs S; Kroesen BJ; Poppema S; van den Berg A
Genes Chromosomes Cancer; 2006 Feb; 45(2):147-53. PubMed ID: 16235244
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo.
Leucci E; Zriwil A; Gregersen LH; Jensen KT; Obad S; Bellan C; Leoncini L; Kauppinen S; Lund AH
Oncogene; 2012 Dec; 31(49):5081-9. PubMed ID: 22310293
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of Hodgkin lymphoma.
Küppers R
Hematology Am Soc Hematol Educ Program; 2009; ():491-6. PubMed ID: 20008234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
